MEDIFAST INC financial data

Symbol
MED on NYSE
Location
Baltimore, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 387% % 37%
Quick Ratio 62% % 9.1%
Debt-to-equity 29% % -35%
Return On Equity 0.12% % -97%
Return On Assets 0.09% % -96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,991,273 shares 0.49%
Common Stock, Shares, Outstanding 10,991,000 shares 0.49%
Entity Public Float $230,000,000 USD -77%
Common Stock, Value, Issued $11,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 10,991,000 shares 0.49%
Weighted Average Number of Shares Outstanding, Diluted 10,991,000 shares 0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $429,695,000 USD -36%
Cost of Revenue $118,428,000 USD -33%
Operating Income (Loss) $5,701,000 USD -153%
Nonoperating Income (Expense) $7,719,000 USD 425%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,018,000 USD -84%
Income Tax Expense (Benefit) $1,771,000 USD -64%
Net Income (Loss) Attributable to Parent $247,000 USD -97%
Earnings Per Share, Basic 0 USD/shares -95%
Earnings Per Share, Diluted 0 USD/shares -97%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $99,526,000 USD -14%
Cash, Cash Equivalents, and Short-term Investments $172,812,000 USD 0.09%
Inventory, Net $23,205,000 USD -42%
Assets, Current $207,838,000 USD -7.6%
Deferred Income Tax Assets, Net $12,108,000 USD 203%
Property, Plant and Equipment, Net $32,846,000 USD -16%
Operating Lease, Right-of-Use Asset $8,397,000 USD -32%
Other Assets, Noncurrent $7,020,000 USD -36%
Assets $268,209,000 USD -7.9%
Contract with Customer, Liability, Current $316,000 USD -45%
Liabilities, Current $46,713,000 USD -35%
Operating Lease, Liability, Noncurrent $6,790,000 USD -41%
Liabilities $53,503,000 USD -36%
Accumulated Other Comprehensive Income (Loss), Net of Tax $220,000 USD -37%
Retained Earnings (Accumulated Deficit) $176,242,000 USD 0.15%
Stockholders' Equity Attributable to Parent $214,706,000 USD 3.6%
Liabilities and Equity $268,209,000 USD -7.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,406,000 USD -53%
Net Cash Provided by (Used in) Financing Activities $563,000 USD 62%
Net Cash Provided by (Used in) Investing Activities $2,054,000 USD 26%
Common Stock, Shares Authorized 20,000,000 shares 0%
Common Stock, Shares, Issued 10,991,000 shares 0.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $789,000 USD -74%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $99,526,000 USD -14%
Deferred Tax Assets, Valuation Allowance $1,624,000 USD -3.3%
Deferred Tax Assets, Gross $20,478,000 USD 0.09%
Operating Lease, Liability $12,261,000 USD -30%
Payments to Acquire Property, Plant, and Equipment $1,522,000 USD -17%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $118,000 USD -98%
Lessee, Operating Lease, Liability, to be Paid $12,671,000 USD -31%
Property, Plant and Equipment, Gross $95,868,000 USD -2.9%
Operating Lease, Liability, Current $5,471,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,789,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,783,000 USD -26%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) $20,000 USD -82%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $410,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,895,000 USD 13%
Deferred Tax Assets, Operating Loss Carryforwards $2,730,000 USD -5.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,500,000 shares 0%
Unrecognized Tax Benefits $7,433,000 USD -0.92%
Lessee, Operating Lease, Liability, to be Paid, Year Four $525,000 USD -80%
Operating Lease, Payments $1,600,000 USD 2.4%
Additional Paid in Capital $38,233,000 USD 23%
Depreciation, Depletion and Amortization $3,280,000 USD 0.58%
Share-based Payment Arrangement, Expense $7,599,000 USD -0.33%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%